Literature DB >> 7410283

Ro 13-9904: A cephalosporin with a high degree of activity and broad antibacterial activity: an invitro comparative study.

R Wise, A P Gillett, J M Andrews, K A Bedford.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7410283     DOI: 10.1093/jac/6.5.595

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  22 in total

Review 1.  In vitro antibacterial effects of cephalosporins.

Authors:  J D Williams; F Moosdeen
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 2.  Seventy-Five Years of Research on Protein Binding.

Authors:  Axel Dalhoff
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

3.  A pharmacokinetic and tolerance study of Ro13-9904, a new cephalosporin antibiotic.

Authors:  M E Pickup; H A Bird; J R Lowe; L Lees; V Wright
Journal:  Br J Clin Pharmacol       Date:  1981-08       Impact factor: 4.335

4.  Comparative synergistic activity of ceftriaxone-piperacillin versus ceftriaxone-netilmicin.

Authors:  K Machka; R Dietz
Journal:  Eur J Clin Microbiol       Date:  1983-10       Impact factor: 3.267

5.  The potential uses of ceftriaxone.

Authors:  W M Scheld
Journal:  Eur J Clin Microbiol       Date:  1983-10       Impact factor: 3.267

6.  The pharmacokinetics of cefotaxime and ceftriaxone in renal and hepatic dysfunction.

Authors:  R Wise; N Wright
Journal:  Infection       Date:  1985       Impact factor: 3.553

7.  In vitro susceptibility of Salmonella to various antimicrobial agents, including a new cephalosporin, Ro 13-9904.

Authors:  P Y Chau; W S Ng; J Ling; K Arnold
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

Review 8.  Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  D M Richards; R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-06       Impact factor: 9.546

9.  Ceftriaxone (Ro 13-9904) therapy of serious infection.

Authors:  R W Bradsher
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

10.  Efficacy of a twelve-hourly ceftriaxone regimen in the treatment of serious bacterial infections.

Authors:  M J Maslow; J F Levine; A A Pollock; M S Simberkoff; J J Rahal
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.